438 related articles for article (PubMed ID: 21331986)
21. MUC1, MUC2, MUC5AC, and MUC6 expressions in gastric carcinomas: their roles as prognostic indicators.
Lee HS; Lee HK; Kim HS; Yang HK; Kim YI; Kim WH
Cancer; 2001 Sep; 92(6):1427-34. PubMed ID: 11745219
[TBL] [Abstract][Full Text] [Related]
22. Alterations of MUC1 and MUC3 expression in gastric carcinoma: relevance to patient clinicopathological features.
Wang RQ; Fang DC
J Clin Pathol; 2003 May; 56(5):378-84. PubMed ID: 12719460
[TBL] [Abstract][Full Text] [Related]
23. Mucinous phenotype and CD10 expression of primary adenocarcinoma of the small intestine.
Kumagai R; Kohashi K; Takahashi S; Yamamoto H; Hirahashi M; Taguchi K; Nishiyama K; Oda Y
World J Gastroenterol; 2015 Mar; 21(9):2700-10. PubMed ID: 25759539
[TBL] [Abstract][Full Text] [Related]
24. Differential expression of the chromosome 11 mucin genes in colorectal cancer.
Sylvester PA; Myerscough N; Warren BF; Carlstedt I; Corfield AP; Durdey P; Thomas MG
J Pathol; 2001 Oct; 195(3):327-35. PubMed ID: 11673830
[TBL] [Abstract][Full Text] [Related]
25. Evaluation of MUC1, MUC2, MUC5AC, and MUC6 Expression Differences in Lung Adenocarcinoma Subtypes by Using a Final Immunoreactivity Score (FIRS).
Buyuk M; Ozluk Y; Bakkaloglu DV; Ozkan B; Firat P; Yilmazbayhan D
Turk Patoloji Derg; 2023; 39(1):64-74. PubMed ID: 36367122
[TBL] [Abstract][Full Text] [Related]
26. Immunohistochemical study of Muc1, Muc2 and human gastric mucin in breast carcinoma: relationship with prognostic factors.
Xu Y; Kimura N; Yoshida R; Lin H; Yoshinaga K
Oncol Rep; 2001; 8(5):1177-82. PubMed ID: 11496338
[TBL] [Abstract][Full Text] [Related]
27. Immunohistochemical study of MUC1, MUC2 and MUC5AC in colorectal carcinoma and review of literature.
Kesari MV; Gaopande VL; Joshi AR; Babanagare SV; Gogate BP; Khadilkar AV
Indian J Gastroenterol; 2015 Jan; 34(1):63-7. PubMed ID: 25731647
[TBL] [Abstract][Full Text] [Related]
28. Clinical significance of MUC1 and MUC2 mucin and p53 protein expression in colorectal carcinoma.
Matsuda K; Masaki T; Watanabe T; Kitayama J; Nagawa H; Muto T; Ajioka Y
Jpn J Clin Oncol; 2000 Feb; 30(2):89-94. PubMed ID: 10768872
[TBL] [Abstract][Full Text] [Related]
29. Expression of mucin antigens in human cancers and its relationship with malignancy potential.
Yonezawa S; Sato E
Pathol Int; 1997 Dec; 47(12):813-30. PubMed ID: 9503463
[TBL] [Abstract][Full Text] [Related]
30. Gene expression of gastric type mucin (MUC5AC) in pancreatic tumors: its relationship with the biological behavior of the tumor.
Yonezawa S; Horinouchi M; Osako M; Kubo M; Takao S; Arimura Y; Nagata K; Tanaka S; Sakoda K; Aikou T; Sato E
Pathol Int; 1999 Jan; 49(1):45-54. PubMed ID: 10227724
[TBL] [Abstract][Full Text] [Related]
31. Mucinous gastric carcinomas: clinicopathologic and molecular analyses.
Choi JS; Kim MA; Lee HE; Lee HS; Kim WH
Cancer; 2009 Aug; 115(15):3581-90. PubMed ID: 19479974
[TBL] [Abstract][Full Text] [Related]
32. Relationship between immunoexpression of mucin peptide cores MUC1 and MUC2 and Lauren's histologic subtypes of gastric carcinomas.
Barresi V; Vitarelli E; Grosso M; Tuccari G; Barresi G
Eur J Histochem; 2006; 50(4):301-9. PubMed ID: 17213039
[TBL] [Abstract][Full Text] [Related]
33. Gastric mucin expression in first-degree relatives of gastric cancer patients.
Boltin D; Gingold-Belfer R; Dickman R; Halpern M; Morgenstern S; Roth M; Layfer O; Vilkin A; Niv Y; Levi Z
Eur J Gastroenterol Hepatol; 2014 Jul; 26(7):710-4. PubMed ID: 24901817
[TBL] [Abstract][Full Text] [Related]
34. Identification of novel biomarkers, MUC5AC, MUC1, KRT7, GAPDH, CD44 for gastric cancer.
Yang J
Med Oncol; 2020 Mar; 37(5):34. PubMed ID: 32219571
[TBL] [Abstract][Full Text] [Related]
35. Differential expression of MUC1, MUC2, and MUC5AC in carcinomas of various sites: an immunohistochemical study.
Lau SK; Weiss LM; Chu PG
Am J Clin Pathol; 2004 Jul; 122(1):61-9. PubMed ID: 15272531
[TBL] [Abstract][Full Text] [Related]
36. Expression of MUC1 and MUC2 mucins in gastric carcinomas: its relationship with the prognosis of the patients.
Utsunomiya T; Yonezawa S; Sakamoto H; Kitamura H; Hokita S; Aiko T; Tanaka S; Irimura T; Kim YS; Sato E
Clin Cancer Res; 1998 Nov; 4(11):2605-14. PubMed ID: 9829723
[TBL] [Abstract][Full Text] [Related]
37. Expression of MUC1 and MUC2 mucin gene products in human ovarian carcinomas.
Feng H; Ghazizadeh M; Konishi H; Araki T
Jpn J Clin Oncol; 2002 Dec; 32(12):525-9. PubMed ID: 12578901
[TBL] [Abstract][Full Text] [Related]
38. Prognostic significance of mucin expression profiles in breast carcinoma with signet ring cells: a clinicopathological study.
Ohashi R; Hayama A; Yanagihara K; Yamashita K; Sakatani T; Takei H; Naito Z
Diagn Pathol; 2016 Nov; 11(1):131. PubMed ID: 27846863
[TBL] [Abstract][Full Text] [Related]
39. Differential expression of mucin 1 and mucin 2 in colorectal cancer.
Kasprzak A; Siodła E; Andrzejewska M; Szmeja J; Seraszek-Jaros A; Cofta S; Szaflarski W
World J Gastroenterol; 2018 Sep; 24(36):4164-4177. PubMed ID: 30271081
[TBL] [Abstract][Full Text] [Related]
40. Expression of mucins (MUC1, MUC2, MUC3, MUC4, MUC5AC and MUC6) and their prognostic significance in human breast cancer.
Rakha EA; Boyce RW; Abd El-Rehim D; Kurien T; Green AR; Paish EC; Robertson JF; Ellis IO
Mod Pathol; 2005 Oct; 18(10):1295-304. PubMed ID: 15976813
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
